Peripheral Registry of Endovascular Clinical Outcomes "The PRIME Registry"

Completed

Conditions studied: Peripheral Arterial Disease, Peripheral Vascular Disease, Critical Limb Ischemia

In brief

The PRIME Registry is a multi-center, observational study designed to evaluate immediate and long-term outcomes (36 months) of endovascular revascularization in patients with critical limb ischemia (CLI) and advanced peripheral artery disease (PAD).

Key facts

Study ID

NCT02786173

Run by

Metro Health, Michigan

People needed

1000

Starts

2013-01-01

Expected to finish

2021-11-05

Last updated by the study team

2023-03-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are to receive or have received lower extremity endovascular intervention
• Rutherford III-VI Classification
• Ability to provide informed consent within 30 day prior to 60 days post index endovascular intervention.
• Ability to follow up at enrollment site.

You may not qualify if…

• Inability or unwillingness to consent for participation in the registry.

Where it is running

• Orlando Health — Orlando, Florida, United States
• Prairie Heart — Springfield, Illinois, United States
• Metro Health Hospital — Wyoming, Michigan, United States
• Cox Health — Springfield, Missouri, United States
• Rex Healthcare — Raleigh, North Carolina, United States
• The Hospitals of Providence — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.